09:52 AM EST - Oncolytics Biotech Inc : Announces that Investorideas.com, a global investor news source covering biotech and pharma stocks issues a sector snapshot on cancer immunotherapy featuring Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a clinical-stage immunotherapeutics company focused on oncology. Oncolytics Biotech Inc
shares T.ONC are trading +$0.03 at $1.56.
Full Press Release: https://www.baystreet.ca/quotedata/quote.aspx?ticker=ONCY&qmodStoryID=7948049441153722
